FindTrial
Sign In

Effect of CRP blood test in management of COVID 19 patients

Impact of CRP test in management of COVID 19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026902
Enrollment
100
Registered
2020-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Control Intervention1: NIL: NIL

Sponsors

GCS Medical College Hospital and Research Centre
Lead Sponsor
GCS Medical College Hospital and Research Centre
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All patients presented to GCSMCH AND RC with respiratory symptoms of all age groups

Exclusion criteria

Exclusion criteria: Known case of carcinoma Known case of Inflammatory bowel disease Known case of Arthritis

Design outcomes

Primary

MeasureTime frame
To assess CRP levels in early stage of COVID-19 To assess the usefulness of CRP test to predict the risk of clinical deterioration of COVID-19 patients. To assess comparison between CRP level and other bio-markers used for COVID-19 patient management. To evaluate correlation between CRP levels and case fatality in COVID 19 patients. Timepoint: 6 months—

Secondary

MeasureTime frame
Demographic distribution of cases of COVID 19Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr Sachin M Darji

GCS Medical College Hospital and Research Centre

sachindarji1409@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026